Case-control association mapping by proxy using family history of disease

Nature Genetics

Volumn 49, Issue 3, 2017, Pages 325-331

  Liu, Jimmy Z ^a   Erlich, Yaniv ^a,b   Pickrell, Joseph K ^a,c  

^a NEW YORK GENOME CENTER   (United States)

^b Columbia University ^*  (United States)

^c Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BIOBANK; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; FIRST-DEGREE RELATIVE; GENE FREQUENCY; GENE LOCUS; GENE MAPPING; GENOME-WIDE ASSOCIATION STUDY; HUMAN; IMMUNOSURVEILLANCE; MAJOR CLINICAL STUDY; MALE; META ANALYSIS (TOPIC); NON INSULIN DEPENDENT DIABETES MELLITUS; PHENOTYPE; PRIORITY JOURNAL; PROXY; UNITED KINGDOM; GENETIC PREDISPOSITION; GENETICS; HUMAN GENOME; META ANALYSIS; PROCEDURES; RISK;

ALZHEIMER DISEASE; CASE-CONTROL STUDIES; CORONARY ARTERY DISEASE; DIABETES MELLITUS, TYPE 2; GENETIC PREDISPOSITION TO DISEASE; GENOME, HUMAN; GENOME-WIDE ASSOCIATION STUDY; HUMANS; RISK;

EID: 85009815269     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng.3766     Document Type: Article

References (51)

1. Sudlow, C. et al. UK Biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 12, e1001779 (2015).
2. Eriksson, N. et al. Web-based, participant-driven studies yield novel genetic associations for common traits. PLoS Genet. 6, e1000993 (2010).
3. Hayes, B.J., Bowman, P.J., Chamberlain, A.J. & Goddard, M.E. Genomic selection in dairy cattle: progress and challenges. J. Dairy Sci. 92, 433-443 (2009).
4. Garrick, D.J., Taylor, J.F. & Fernando, R.L. Deregressing estimated breeding values and weighting information for genomic regression analyses. Genet. Sel. Evol. 41, 55 (2009).
5. Cole, J.B. et al. Distribution and location of genetic effects for dairy traits. J. Dairy Sci. 92, 2931-2946 (2009).
6. Visscher, P.M. & Duffy, D.L. The value of relatives with phenotypes but missing genotypes in association studies for quantitative traits. Genet. Epidemiol. 30, 30-36 (2006).
7. Chen, W.-M. & Abecasis, G.R. Family-based association tests for genomewide association scans. Am. J. Hum. Genet. 81, 913-926 (2007).
8. Barzilai, N. et al. Unique lipoprotein phenotype and genotype associated with exceptional longevity. J. Am. Med. Assoc. 290, 2030-2040 (2003).
9. Joshi, P.K. et al. Variants near CHRNA3/5 and APOE have age-and sex-related effects on human lifespan. Nat. Commun. 7, 11174 (2016).
10. Pilling, L.C. et al. Human longevity is influenced by many genetic variants: evidence from 75,000 UK Biobank participants. Aging 8, 547-560 (2016).
11. Tan, Q., Zhao, J.H., Li, S., Kruse, T.A. & Christensen, K. Power assessment for genetic association study of human longevity using offspring of long-lived subjects. Eur. J. Epidemiol. 25, 501-506 (2010).
12. Gudbjartsson, D.F. et al. Many sequence variants affecting diversity of adult human height. Nat. Genet. 40, 609-615 (2008).
13. Kong, A. et al. Parental origin of sequence variants associated with complex diseases. Nature 462, 868-874 (2009).
14. Thornton, T. & McPeek, M.S. Case-control association testing with related individuals: a more powerful quasi-likelihood score test. Am. J. Hum. Genet. 81, 321-337 (2007).
15. Hebert, L.E., Scherr, P.A., Bienias, J.L., Bennett, D.A. & Evans, D.A. Alzheimer disease in the US population: prevalence estimates using the 2000 census. Arch. Neurol. 60, 1119-1122 (2003).
16. de Lau, L.M. & Breteler, M.M. Epidemiology of Parkinson's disease. Lancet Neurol. 5, 525-535 (2006).
17. Corder, E.H. et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261, 921-923 (1993).
18. Danesh, J., Collins, R. & Peto, R. Lipoprotein(a) and coronary heart disease. Meta-analysis of prospective studies. Circulation 102, 1082-1085 (2000).
19. Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447, 661-678 (2007).
20. International Consortium for Blood Pressure Genome-Wide Association Studies. Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature 478, 103-109 (2011).
21. Hunter, D.J. et al. A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat. Genet. 39, 870-874 (2007).
22. Grant, S.F.A. et al. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat. Genet. 38, 320-323 (2006).
23. Hung, R.J. et al. A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature 452, 633-637 (2008).
24. Nalls, M.A. et al. Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease. Nat. Genet. 46, 989-993 (2014).
25. Sasieni, P.D. From genotypes to genes: doubling the sample size. Biometrics 53, 1253-1261 (1997).
26. International Schizophrenia Consortium. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 460, 748-752 (2009).
27. Lambert, J.-C. et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat. Genet. 45, 1452-1458 (2013).
28. CARDIoGRAMplusC4D Consortium. A comprehensive 1000 Genomes-based genome-wide association meta-analysis of coronary artery disease. Nat. Genet. 47, 1121-1130 (2015).
29. DIAbetes Genetics Replication And Meta-analysis (DIAGRAM) Consortium. et al. Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility. Nat. Genet. 46, 234-244 (2014).
30. Ripke, S. et al. A mega-analysis of genome-wide association studies for major depressive disorder. Mol. Psychiatry 18, 497-511 (2013).
31. Friedmann, E. et al. Consensus analysis of signal peptide peptidase and homologous human aspartic proteases reveals opposite topology of catalytic domains compared with presenilins. J. Biol. Chem. 279, 50790-50798 (2004).
32. Chan, G. et al. CD33 modulates TREM2: convergence of Alzheimer loci. Nat. Neurosci. 18, 1556-1558 (2015).
33. Gjoneska, E. et al. Conserved epigenomic signals in mice and humans reveal immune basis of Alzheimer's disease. Nature 518, 365-369 (2015).
34. Kurogane, Y. et al. FGD5 mediates proangiogenic action of vascular endothelial growth factor in human vascular endothelial cells. Arterioscler. Thromb. Vasc. Biol. 32, 988-996 (2012).
35. Taimeh, Z., Loughran, J., Birks, E.J. & Bolli, R. Vascular endothelial growth factor in heart failure. Nat. Rev. Cardiol. 10, 519-530 (2013).
36. Garner, K. et al. Phosphatidylinositol transfer protein, cytoplasmic 1 (PITPNC1) binds and transfers phosphatidic acid. J. Biol. Chem. 287, 32263-32276 (2012).
37. Dolgin, E. Personalized investigation. Nat. Med. 16, 953-955 (2010).
38. Ledford. H. Genome hacker uncovers largest-ever family tree. Nature http://dx.doi.org/10.1038/nature.2013.14037 (2013).
39. Campbell, D.D., Sham, P.C., Knight, J., Wickham, H. & Landau, S. Software for generating liability distributions for pedigrees conditional on their observed disease states and covariates. Genet. Epidemiol. 34, 159-170 (2010).
40. Hayeck, T.J. et al. Mixed model with correction for case-control ascertainment increases association power. Am. J. Hum. Genet. 96, 720-730 (2015).
41. Weissbrod, O., Lippert, C., Geiger, D. & Heckerman, D. Accurate liability estimation improves power in ascertained case-control studies. Nat. Methods 12, 332-334 (2015).
42. Delaneau, O., Marchini, J. & 1000 Genomes Project Consortium. Integrating sequence and array data to create an improved 1000 Genomes Project haplotype reference panel. Nat. Commun. 5, 3934 (2014).
43. Howie, B.N., Donnelly, P. & Marchini, J. A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet. 5, e1000529 (2009).
44. UK10K Consortium. The UK10K project identifies rare variants in health and disease. Nature 526, 82-90 (2015).
45. 1000 Genomes Project Consortium. A global reference for human genetic variation. Nature 526, 68-74 (2015).
46. Rafnar, T. et al. Mutations in BRIP1 confer high risk of ovarian cancer. Nat. Genet. 43, 1104-1107 (2011).
47. Burdick, J.T., Chen, W.-M., Abecasis, G.R. & Cheung, V.G. In silico method for inferring genotypes in pedigrees. Nat. Genet. 38, 1002-1004 (2006).
48. Chang, C.C. et al. Second-generation PLINK: rising to the challenge of larger and richer datasets. Gigascience 4, 7 (2015).
49. Bulik-Sullivan, B. et al. An atlas of genetic correlations across human diseases and traits. Nat. Genet. 47, 1236-1241 (2015).
50. Loh, P.-R. et al. Efficient Bayesian mixed-model analysis increases association power in large cohorts. Nat. Genet. 47, 284-290 (2015).
51. Yang, J. et al. Conditional and joint multiple-SNP analysis of GWAS summary statistics identifies additional variants influencing complex traits. Nat. Genet. 44, 369-375, S1-S3 (2012).